Tag: health

FDA Withdraws Approval for TG Therapeutics Cancer Treatment

The U.S. Food and Drug Administration said on Wednesday it has withdrawn its approval for TG Therapeutics Inc.’s lymphatic cancer treatment Ukoniq over concerns of higher risk of death in patients receiving the drug. Ukoniq received accelerated approval in the United States in February last year to treat adult patients with marginal zone lymphoma who…


What’s Bugging You: The Parasite-Cancer Connection

The common misconception that parasites are a problem only in third world countries is, to be frank, outdated, archaic, and downright damaging. Ask any veterinarian and he/she will tell you that the soil, surface water, as well as both wild and domesticated animals here in America are just as infested with parasites as any place…


The Growing Possibility of a Real 6 Million Dollar Man

Steve Austin was a U.S. astronaut who was gravely injured when his spacecraft crashed back to earth. He was rebuilt, almost from the ground up by government-approved experimental surgeries, giving him powerful prosthetics. The “Six Million Dollar Man” first aired in 1973, starring Lee Majors, and it ran for five seasons. I remember that show,…


Blueberry Chia Seed Pudding (Recipe)

Everyone loves a good snack, but unfortunately when the “snack attack” comes we usually make poor choices and end up regretting it sometime later. Fortunately, it doesn’t have to be this way and with a little preparation skills you can put together a healthy, delicious, and filling snack that will keep your body and brain…


CDC Director Issues Alert on Pfizer’s COVID-19 Pill: ‘You Might Get Symptoms Again’

Centers for Disease Control and Prevention Director Rochelle Walensky warned that Pfizer’s COVID-19 pill Paxlovid can lead to a rebound in symptoms. “If you take Paxlovid, you might get symptoms again,” Walensky told CBS News on Tuesday. “We haven’t yet seen anybody who has returned with symptoms needing to go to the hospital. So, generally,…


CDC Director Issues Alert on Pfizer’s COVID-19 Pill

Centers for Disease Control and Prevention Director Rochelle Walensky warned that Pfizer’s COVID-19 pill Paxlovid can lead to a rebound in symptoms. “If you take Paxlovid, you might get symptoms again,” Walensky told CBS News on Tuesday. “We haven’t yet seen anybody who has returned with symptoms needing to go to the hospital. So, generally,…


Biden Administration to Keep Higher Medicare Premiums Despite Ruling on Key Drug

Higher Medicare premiums will remain in place at least until the end of the year, President Joe Biden administration has announced. The premiums were increased for 2022 because of uncertainty surrounding the Alzheimer’s drug Aduhelm. The Medicare Part B monthly rate was hiked 14.5 percent to $170.10. The assumed costs for the drug, though, are lower…


Despite Hormone Therapy, Transgender Athletes Have Unfair Advantage Over Biological Women: Doctors

Male-born transgender athletes retain their physical advantages over biological female opponents, even after taking testosterone suppressants, doctors said. In an interview with The New York Times, a Mayo Clinic doctor, an international physiologist, and a Harvard University evolutionary biologist offered their take on the performance of transgender swimmer Lia Thomas, who competed as a woman…


‘Unprecedented,’ Over 25 Percent Rise in Suspected Poison Suicides Attempts in Children: Toxicology Doctor

A study on the National Poison Data System (NPDS) has found that suspected suicide attempts via self-poisoning in children have increased by 26.7 percent from 2015 to 2020 with researchers highlighting the nation’s increasing mental health crisis amongst adolescents. “Our study is one of a number that demonstrates that we are experiencing an unprecedented mental…


More Evidence for Early Treatment

Trial Site News knocked it out of the park with their May 22, 2022 article entitled: “Opinion: What have We Learned about Early Treatment During the COVID-19 Pandemic?” I strongly encourage people to read the full article, but the quoted sections of the article below highlight key points. For the many of articles published by…